These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8619784)

  • 41. A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia.
    Mandell LA; Nicolle LE; Ronald AR; Duperval R; Robson HG; Feld R; Vincelette J; Fong I
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():9-20. PubMed ID: 6352661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating Infectious Keratitis.
    Cunningham ET; Acharya NR; Akpek EK; Zierhut M
    Ocul Immunol Inflamm; 2016 Oct; 24(5):479-81. PubMed ID: 27681115
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent cluster of childhood microbial keratitis due to orthokeratology.
    Tran T; Samarawickrama C; Petsoglou C; Watson S
    Clin Exp Ophthalmol; 2014 Nov; 42(8):793-4. PubMed ID: 24533751
    [No Abstract]   [Full Text] [Related]  

  • 46. Rationale for adjunctive topical corticosteroids in bacterial keratitis.
    Hindman HB; Patel SB; Jun AS
    Arch Ophthalmol; 2009 Jan; 127(1):97-102. PubMed ID: 19139348
    [No Abstract]   [Full Text] [Related]  

  • 47. Problems with monotherapy for bacterial keratitis.
    Guzek JP
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6902-3; author reply 6903. PubMed ID: 21123792
    [No Abstract]   [Full Text] [Related]  

  • 48. Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.
    Kaye S; Tuft S; Neal T; Tole D; Leeming J; Figueiredo F; Armstrong M; McDonnell P; Tullo A; Parry C
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):362-8. PubMed ID: 19684005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The steroid controversy in bacterial keratitis.
    Acharya NR; Srinivasan M; Mascarenhas J; Ravindran M; Rajaraman R; Zegans M; McLeod S; Lietman TM
    Arch Ophthalmol; 2009 Sep; 127(9):1231. PubMed ID: 19752446
    [No Abstract]   [Full Text] [Related]  

  • 50. Corynebacterium striatus keratitis.
    Heidemann DG; Dunn SP; Diskin JA; Aiken TB
    Cornea; 1991 Jan; 10(1):81-2. PubMed ID: 2019113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
    Gritz DC; McDonnell PJ; Lee TY; Tang-Liu D; Hubbard BB; Gwon A
    Cornea; 1992 Mar; 11(2):143-7. PubMed ID: 1582217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudomonas corneal ulcer associated with disposable soft contact lenses.
    Kent HD; Sanders RJ; Arentsen JJ; Cohen EJ; Laibson PR
    CLAO J; 1989; 15(4):264-5. PubMed ID: 2805313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
    Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
    Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ciprofloxacin monotherapy and bacterial keratitis.
    Katz HR
    Ophthalmology; 1999 Oct; 106(10):1853-4. PubMed ID: 10519570
    [No Abstract]   [Full Text] [Related]  

  • 56. The case against the use of steroids in the treatment of bacterial keratitis.
    Cohen EJ
    Arch Ophthalmol; 2009 Jan; 127(1):103-4. PubMed ID: 19139349
    [No Abstract]   [Full Text] [Related]  

  • 57. Controversies in management of bacterial keratitis.
    Charukamnoetkanok P; Pineda R
    Int Ophthalmol Clin; 2005; 45(4):199-210. PubMed ID: 16199977
    [No Abstract]   [Full Text] [Related]  

  • 58. Pseudomonas keratitis.
    Yilmaz S; Saklamaz A; Maden A
    Ophthalmology; 2006 May; 113(5):883-4. PubMed ID: 16650685
    [No Abstract]   [Full Text] [Related]  

  • 59. Mycobacterium chelonae keratitis after laser-assisted subepithelial keratectomy.
    Rodriguez B; Holzinger KA; Le LH; Winkle RK; Allen RD
    J Cataract Refract Surg; 2006 Jun; 32(6):1059-61. PubMed ID: 16814072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics of Pseudomonas corneal infection related to orthokeratology.
    Araki-Sasaki K; Nishi I; Yonemura N; Takatsuka H; Mutoh K; Matsumoto K; Asari S; Tanihara H
    Cornea; 2005 Oct; 24(7):861-3. PubMed ID: 16160505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.